Research Article
The Landscape of Using Glycosyltransferase Gene Signatures for Overall Survival Prediction in Hepatocellular Carcinoma
Table 1
The detailed clinical characteristics of patients with hepatocellular carcinoma between the training and validation sets of TCGA database.
| | | Total (n = 371) | Dataset | | Training set (n = 260) | Validation (n = 111) | value |
| | Gender | | | | 0.2 | | Male | 250 (67.4%) | 181 (69.6%) | 69 (62.2%) | | | Female | 121 (32.6%) | 79 (30.4%) | 42 (37.8%) | | | Age | | | | 0.855 | | <60 | 169 (45.6%) | 117 (45.0%) | 52 (46.8%) | | | ≥60 | 201 (54.2%) | 142 (54.6%) | 59 (53.2%) | | | Missing | 1 (0.3%) | 1 (0.4%) | 0 (0%) | | | Stage | | | | 0.12 | | Stage I | 171 (46.1%) | 129 (49.6%) | 42 (37.8%) | | | Stage II | 86 (23.2%) | 61 (23.5%) | 25 (22.5%) | | | Stage III | 85 (22.9%) | 52 (20.0%) | 33 (29.7%) | | | Stage IV | 5 (1.3%) | 3 (1.2%) | 2 (1.8%) | | | Missing | 24 (6.5%) | 15 (5.8%) | 9 (8.1%) | | | T | | | | 0.077 | | TX | 1 (0.3%) | 0 (0%) | 1 (0.9%) | | | T1 | 181 (48.8%) | 136 (52.3%) | 45 (40.5%) | | | T2 | 94 (25.3%) | 65 (25.0%) | 29 (26.1%) | | | T3 | 80 (21.6%) | 48 (18.5%) | 32 (28.8%) | | | T4 | 13 (3.5%) | 9 (3.5%) | 4 (3.6%) | | | Missing | 2 (0.5%) | 2 (0.8%) | 0 (0%) | | | M | | | | 0.826 | | M0 | 266 (71.7%) | 184 (70.8%) | 82 (73.9%) | | | M1 | 4 (1.1%) | 3 (1.2%) | 1 (0.9%) | | | MX | 101 (27.2%) | 73 (28.1%) | 28 (25.2%) | | | Treatment | | | | 0.149 | | Pharmaceutical therapy, NOS | 180 (48.5%) | 133 (51.2%) | 47 (42.3%) | | | Radiation therapy, NOS | 191 (51.5%) | 127 (48.8%) | 64 (57.7%) | |
|
|
